EGFR alterations have been implicated in the carcinogenesis of many malignancies and thus been considered as a well-established onco-therapeutic target of a plethora of cancers such as colorectal cancer, non-small cell lung cancer, as well as head and neck squamous cell carcinoma52. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.